CONMED (CNMD) PT Raised to $150 as Stifel Checks Indicate Growth Could Accelerate to Double Digits
Tweet Send to a Friend
Stifel analyst Rick Wise raised the price target on CONMED (NASDAQ: CNMD) to $150.00 (from $127.00) while maintaining a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
